| abstract |
The present invention relates to 4- (1-ethyl-propoxy) -3,6-dimethyl-2- (2,4,6-trimethyl-phenoxy) -pyridine and (3,6-dimethyl-2- (2,4) , 6-trimethyl-phenoxy) -pyridin-4-yl)-(1-ethyl-propyl) -amine or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier or diluent A pharmaceutical composition for treating heart failure in an animal. The invention also relates to a composition comprising the two agents together with other hemorrhagic heart failure therapeutic compounds for the treatment of hemorrhagic heart failure. |